NCT04437095

Brief Summary

The purpose of this study is to assess the use of an audio recording containing positive suggestion as a means to provide needed psychological support to critically ill patients in a feasible and reliable manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
149

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 18, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

August 17, 2020

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 7, 2025

Completed
Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

4.5 years

First QC Date

June 11, 2020

Last Update Submit

March 25, 2025

Conditions

Keywords

Post traumatic stress syndromeAnxietyDepressionPICS

Outcome Measures

Primary Outcomes (1)

  • Hospital Anxiety and Depression Scale (HADS) - Anxiety

    A self-reported questionnaire designed to identify anxiety and depression. Each item is rated on a 4-point scale from 0 "absence" to 3 "extreme presence". Total score is 21 per subscale: 0 - 7: Normal levels of anxiety/depression; 8-10: Borderline abnormal; \> 11: Abnormal. Total questions: 14 Anxiety 7 Depression 7 A self-reported questionnaire designed to identify anxiety and depression. Each item is rated on a 4-point scale from 0 "absence" to 3 "extreme presence". Total score is 21. Per subscale: 0 - 7: Normal levels of anxiety/depression; 8-10: Borderline abnormal; \> 11: Abnormal. TL questions: 14: Anxiety 7, Depression 7

    within 96 hours of ICU discharge

Secondary Outcomes (9)

  • Impact of Events Scale-Revised

    within 96 hours of ICU discharge

  • Montreal Cognitive Assessment-Blind (MoCA-blind)

    within 96 hours of ICU discharge

  • EQ-5D

    within 96 hours of ICU discharge

  • Hospital Anxiety and Depression Scale (HADS) - Depression

    within 96 hours of ICU discharge

  • Hospital Anxiety and Depression Scale (HADS) - Depression

    6 months following ICU discharge

  • +4 more secondary outcomes

Study Arms (2)

PSBPS Audiorecording

EXPERIMENTAL

Thirty minute daily administration of audio recording containing messages of psychological support based on positive suggestion delivered via headphones

Other: Psychological Support Based on Positive Suggestion delivered via pre-recorded MP3 message

Control

NO INTERVENTION

Standard of care

Interventions

Daily administration of audiorecording

PSBPS Audiorecording

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute respiratory failure and/or requiring vasopressors
  • Admitted to the ICU
  • Expected to stay \>48 hours in the ICU

You may not qualify if:

  • History of dementia
  • History of mental retardation
  • History of suicide attempt
  • History of psychotic disorders such as schizophrenia
  • Acute alcohol/substance intoxication or withdrawal
  • Severe metabolic encephalopathy
  • Patients on comfort care
  • Patients not expected to survive the hospital stay
  • Those with hearing impairment
  • Non-English speaking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Psychological TraumaAnxiety DisordersDepressionStress Disorders, Post-TraumaticCombat Disorders

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Lioudmila Karnatovskaia, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients will be randomized 1:1 to intervention vs standard care. Using data from our prior observational study, mean (SD) HADS-Anxiety subscale was 7.3 (4.1) among these subjects (coefficient of variation = 4.1/7.3 = 0.56). A total 300 subjects will be enrolled and randomized until 100 subjects per arm recruitment target is reached to allow for mortality and dropout. The analysis will compare 6 month HADS-A by treatment arms using ANCOVA. The analysis will be conducted under a modified intention to treat principle, with subjects analyzed according to randomized arm, but excluding patients who die before follow up. Additional outcomes including HADS-D, MoCA-blind, and EQ-5D will be analyzed similarly using ANCOVA, and IES-R subscore\>1.6 will be analyzed by Chi-square test.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 11, 2020

First Posted

June 18, 2020

Study Start

August 17, 2020

Primary Completion

February 7, 2025

Study Completion

February 7, 2025

Last Updated

March 28, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations